LYMPHOGENiX is a leading company for lymphatic vessel regeneration research based in the UK and Japan operating globally
LYMPHOGENiX is a pioneering biotechnology research company focused on lymphatic vessel regeneration, operating globally from its bases in London, UK, and Nagoya, Japan. Situated at the forefront of medical innovation, LYMPHOGENiX is dedicated to revitalizing lymphatic function through proprietary technology, offering potential treatments for a range of medical conditions.
With a vision to improve patient vitality, LYMPHOGENiX is actively developing methods to address critical health challenges such as heart failure and pulmonary fibrosis. The company's research also shows substantial promise in tackling prevalent issues like skin-ageing, obesity, Alzheimer’s Disease, and infertility. LYMPHOGENiX’s primary address is in Covent Garden, London, GB, with additional locations at Harwell Campus in Oxford, Oxfordshire, GB, and Nagoya University in Nagoya, JP.
LYMPHOGENiX remains committed to advancing its cutting-edge research and expanding its impact on global healthcare. The company invites you to explore the potential of lymphatic vessel regeneration and looks forward to shaping the future of medical treatments. We invite the management of LYMPHOGENiX to create a customized and exclusive company showcase and product listing on our platform.
Compare LYMPHOGENiX with 3 companies in Biotechnology-Research
| Comparison Field |
LYMPHOGENiXMain Company |
Katana LondonView Profile |
Molecular IntellectView Profile |
Cour Consultants IncView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2001 | 2025 | 1999 |
|
Company Size
|
— | 11-50 | 2-10 | 2-10 |
|
City
|
Raleigh-Durham, NC | Dallas, Texas | ||
|
Country
|
United States | |||
|
Skills & Keywords
Comparing with main company
|
24 Total Skills
Lymphatic Vessel Regeneration
Biotechnology
Heart Failure Treatment
Pulmonary Fibrosis
Alzheimer's Disease
Regenerative Medicine
Medical Innovation
Nagoya University
skin-ageing
pulmonary fibrosis
infertility
heart failure
Metcela
HFrEF
Japan
HFpEF
Biospire
Alzheimer’s Disease
Harwell
obesity
Lymphatic system
Biotech
UK
Startup
|
17 Total
17 Unique
Unique Skills:
Advertising
Branding
China
Communications
Creative
Culture
+11
|
19 Total
1 Common
18 Unique
Match
4%
Common Skills:
Biotechnology
Unique Skills:
AI
AlphaFold
Artificial Intelligence
Biology
Computational Biochemistry
Computational Biology
+12
|
12 Total
12 Unique
Unique Skills:
C-Suite
Executive Search
Fortune 500
International
MedTech
Nationwide
+6
|
Other organizations in the same industry
This company is also known as